BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23089221)

  • 1. Targeting the kallikrein-related peptidases for drug development.
    Sotiropoulou G; Pampalakis G
    Trends Pharmacol Sci; 2012 Dec; 33(12):623-34. PubMed ID: 23089221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
    Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of kallikrein-related peptidases: An overview.
    Masurier N; Arama DP; El Amri C; Lisowski V
    Med Res Rev; 2018 Mar; 38(2):655-683. PubMed ID: 28609548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
    Goettig P; Magdolen V; Brandstetter H
    Biochimie; 2010 Nov; 92(11):1546-67. PubMed ID: 20615447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
    Swedberg JE; de Veer SJ; Harris JM
    Biol Chem; 2010 Apr; 391(4):357-74. PubMed ID: 20180638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.
    Sotiropoulou G; Pampalakis G
    Biol Chem; 2010 Apr; 391(4):321-31. PubMed ID: 20180637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options.
    Fischer J; Meyer-Hoffert U
    Thromb Haemost; 2013 Sep; 110(3):442-9. PubMed ID: 23446429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
    Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
    Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.
    Cereda V; Formica V; Menghi A; Pellicori S; Roselli M
    Expert Opin Investig Drugs; 2015; 24(7):929-47. PubMed ID: 25858813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.
    de Veer SJ; Furio L; Swedberg JE; Munro CA; Brattsand M; Clements JA; Hovnanian A; Harris JM
    J Invest Dermatol; 2017 Feb; 137(2):430-439. PubMed ID: 27697464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation profiles and regulatory cascades of the human kallikrein-related peptidases.
    Yoon H; Laxmikanthan G; Lee J; Blaber SI; Rodriguez A; Kogot JM; Scarisbrick IA; Blaber M
    J Biol Chem; 2007 Nov; 282(44):31852-64. PubMed ID: 17823117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
    Pasic MD; Olkhov E; Bapat B; Yousef GM
    Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
    Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
    Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology.
    Shaw JL; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):681-8. PubMed ID: 18627298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting kallikrein-related peptidases in prostate cancer.
    Mavridis K; Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2014 Apr; 18(4):365-83. PubMed ID: 24571737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the extended substrate specificity of kallikrein 1-related peptidases.
    Borgoño CA; Gavigan JA; Alves J; Bowles B; Harris JL; Sotiropoulou G; Diamandis EP
    Biol Chem; 2007 Nov; 388(11):1215-25. PubMed ID: 17976015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.
    Yoon H; Blaber SI; Li W; Scarisbrick IA; Blaber M
    Biol Chem; 2013 Jan; 394(1):137-47. PubMed ID: 23241590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional roles of human kallikrein-related peptidases.
    Sotiropoulou G; Pampalakis G; Diamandis EP
    J Biol Chem; 2009 Nov; 284(48):32989-94. PubMed ID: 19819870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspin.
    Ulbricht D; Tindall CA; Oertwig K; Hanke S; Sträter N; Heiker JT
    Biol Chem; 2018 Sep; 399(9):1079-1084. PubMed ID: 29494334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
    Scorilas A; Mavridis K
    Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.